Thursday, January 27, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina



Cuba´s NeuroEPO drug shows positive results to treat Alzheimer’s


Cuba´s NeuroEPO drug shows positive results to treat Alzheimer’s

Havana, Dec 13 (Prensa Latina) 54% of patients treated for Alzheimer's disease during clinical trials with the new Cuban drug NeuroEPO has shown significant clinical results, Cuban scientists assured.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

In a meeting with the Cuban President Miguel Díaz-Canel, the specialists enlightened the encouraging results on improvements in cognitive impairment rate.

According to the experts, in 27 years of experience treating patients suffering from Alzheimer’s they have never seen people showing positive progress.

NeuroEPO´s developers said that registering this neuroprotective drug, Cuba would gain sovereignty in treating Alzheimer’s disease and would also achieve a scientific milestone that other nations have not reached.

This project –carried out by the Center for Molecular Immunology (CIM, in Spanish), the Center for Research and Development of Medicines and other institutions- consisted of developing a novel recombinant human erythropoietin (NeuroEpo) formula, with characteristics similar to that produced by the brain.

Recently, the CIM Clinical Research Director Tania Crombet explained that NeuroEpo is a nasal drug, very comfortable and easy to use.


name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.